SRDX logo

Surmodics, Inc. (SRDX)

Profile

Full Name

Surmodics, Inc.

Ticker

NASDAQ: SRDX

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

March 4, 1998

Indexes

Not included

Website

https://www.surmodics.com

Employees

389

Key Details

Price

$42.98(0.00%)

Market Cap

$614.51M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$126.08M(-4.91% YoY)

Annual EPS

-$0.82(-644.75% YoY)

PE Ratio

-

Next earnings date

Nov 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $42.98
    SRDX price is $42.98

    30-Day Relative Volume

    0.00
    SRDX 30-day relative volume is 0.00

    Price Performance

    Price Most Recent Change

    0%
    SRDX price has remained unchanged on Nov 21, 2025

    Price YTD Change

    +8.54%
    SRDX price is up +8.54% since January 1st

    Price 1-Year Change

    +9.67%
    SRDX price is up +9.67% year-on-year

    Price 3-Year Change

    +19.22%
    SRDX price is up +19.22% over the past 3 years

    Price Range

    Price All-Time High

    $82.35
    SRDX price is currently -47.81% below its historical high of $82.35

    Price 3-Year Low

    $16.00
    SRDX price is currently +168.63% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $614.51M
    SRDX market cap is $614.51 million

    Market Cap 3-Year Change

    +21.41%
    SRDX market cap is up +21.41% over the past 3 years

    Market Cap All-Time High

    $1.07B
    SRDX market cap is currently -42.72% below its historical high of $1.07 billion

    Market Cap Sector Percentile

    64.6%
    SRDX market cap is higher than 64.6% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.2%
    SRDX shares outstanding is down -0.2% year-on-year

    Shares Outstanding 3-Year Change

    +1.83%
    SRDX shares outstanding is up +1.83% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.48
    SRDX beta is 0.48

    200-day SMA

    $31.26
    SRDX price is currently +37.49% above its 200-day simple moving average

    50-day SMA

    $31.33
    SRDX price is currently +37.18% above its 50-day simple moving average

    14-Day RSI

    85.75
    SRDX 14-day relative strength index is 85.75

    Volume

    0.00
    SRDX 30-day relative volume is 0.00

    ATR

    $1.28
    SRDX average true range is $1.28

    10-day Historical Volatility

    246.20%
    SRDX 10-day historical volatility is 246.20%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $126.08M
    SRDX annual revenue is $126.08 million

    Revenue Analysts Estimate

    $117.73M
    SRDX annual revenue is currently +7.09% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    -4.91%
    SRDX annual revenue is down -4.91% year-on-year

    Revenue Sector Percentile

    69.98%
    SRDX annual revenue is higher than 69.98% of companies in Healthcare sector

    EPS

    EPS

    -$0.82
    SRDX annual earnings per share is -$0.82

    EPS Analysts Estimate

    -$0.29
    SRDX annual earnings per share is currently -181.21% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -644.75%
    SRDX annual earnings per share is down -644.75% year-on-year

    EPS Sector Percentile

    60.03%
    SRDX annual earnings per share is higher than 60.03% of companies in Healthcare sector

    Profit

    Gross Profit

    $89.55M
    SRDX annual gross profit is $89.55 million

    Gross Margin

    71.03%
    SRDX annual gross profit margin is 71.03%

    Operating Profit

    -$1.95M
    SRDX annual operating income is -$1.95 million

    Operating Margin

    -30.51%
    SRDX annual operating profit margin is -30.51%

    Net Income

    -$11.54M
    SRDX annual net profit is -$11.54 million

    Net Margin

    -9.15%
    SRDX annual net profit margin is -9.15%

    Expenses

    Total Expenses

    $137.62M
    SRDX annual total expenses is $137.62 million

    Operating Expenses

    $91.50M
    SRDX annual total operating expenses is $91.50 million

    Cost Of Goods Sold

    $36.53M
    SRDX annual cost of goods sold is $36.53 million

    Selling, General & Administrative Expenses

    $56.84M
    SRDX annual SG&A is $56.84 million

    Depreciation & Amortization

    $8.69M
    SRDX annual D&A is $8.69 million

    Interest Expense

    $0.00
    SRDX annual interest expense is $0.00

    Income Tax

    $4.04M
    SRDX annual income tax is $4.04 million

    EBIT & EBITDA

    EBIT

    -$1.95M
    SRDX annual earnings before interest & taxes is -$1.95 million

    EBITDA

    $6.75M
    SRDX annual EBITDA is $6.75 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $178.56M
    SRDX annual total assets is $178.56 million

    Non Current Assets

    $97.26M
    SRDX annual long term assets is $97.26 million

    Current Assets

    $81.30M
    SRDX annual total current assets is $81.30 million

    Cash and Cash Equivalents

    $40.11M
    SRDX annual cash & cash equivalents is $40.11 million

    Accounts Receivable

    $23.16M
    SRDX annual accounts receivable is $23.16 million

    Inventory

    $15.17M
    SRDX annual inventory is $15.17 million

    Liabilities

    Total Liabilities

    $59.66M
    SRDX annual total liabilities is $59.66 million

    Long Term Liabilities

    $6.92M
    SRDX annual total long term liabilities is $6.92 million

    Current Liabilities

    $20.54M
    SRDX annual current liabilities is $20.54 million

    Accounts Payable

    $2.79M
    SRDX annual accounts payable is $2.79 million

    Debt

    Total Debt

    $33.24M
    SRDX annual total debt is $33.24 million

    Total Debt 1-Year Change

    -0.03%
    SRDX annual total debt is down -0.03% year-on-year

    Long Term Debt

    $32.20M
    SRDX annual long term debt is $32.20 million

    Short Term Debt

    $1.04M
    SRDX annual short term debt is $1.04 million

    Equity & Capital

    Shareholders Equity

    $118.90M
    SRDX annual stockholders equity is $118.90 million

    Book Value

    $118.90M
    SRDX annual book value is $118.90 million

    Retained Earnings

    $75.71M
    SRDX annual retained earnings is $75.71 million

    Working Capital

    $60.76M
    SRDX annual working capital is $60.76 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $248.00K
    SRDX annual cash from operations is $248.00 thousand

    Cash From Operations 1-Year Change

    -97.64%
    SRDX annual cash from operations is down -97.64% year-on-year

    Cash From Investing

    -$2.94M
    SRDX annual cash from investing is -$2.94 million

    Cash From Investing 1-Year Change

    +56.95%
    SRDX annual cash from investing is up +56.95% year-on-year

    Cash From Financing

    -$2.95M
    SRDX annual cash from financing is -$2.95 million

    Cash From Financing 1-Year Change

    -116.03%
    SRDX annual cash from financing is down -116.03% year-on-year

    CAPEX

    CAPEX

    $3.49M
    SRDX annual capital expenditures is $3.49 million

    CAPEX 1-Year Change

    +19.67%
    SRDX annual capital expenditures is up +19.67% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$3.24M
    SRDX annual free cash flow is -$3.24 million

    Free Cash Flow 1-Year Change

    -142.71%
    SRDX annual free cash flow is down -142.71% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    71.03%
    SRDX annual gross profit margin is 71.03%

    Operating Margin

    -30.51%
    SRDX annual operating profit margin is -30.51%

    Net Margin

    -9.15%
    SRDX annual net profit margin is -9.15%

    ROA & ROE

    ROA

    -6.34%
    SRDX annual return on assets is -6.34%

    ROE

    -9.67%
    SRDX annual return on equity is -9.67%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    SRDX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    SRDX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    5.52
    SRDX price to book ratio is 5.52

    PB Ratio Sector Percentile

    79.48%
    SRDX price to book ratio is higher than 79.48% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    5.09
    SRDX price to sales ratio is 5.09

    PS Ratio Sector Percentile

    56.62%
    SRDX price to sales ratio is higher than 56.62% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $614.36M
    SRDX enterprise value is $614.36 million

    Enterprise Value Sector Percentile

    66.24%
    SRDX enterprise value is higher than 66.24% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -223.98
    SRDX EV/EBITDA is -223.98

    EV/EBITDA Sector Percentile

    0.09%
    SRDX EV/EBITDA is higher than 0.09% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.96
    SRDX annual current ratio is 3.96

    Quick Ratio

    3.22
    SRDX annual quick ratio is 3.22

    Leverage

    Debt To Equity

    0.28
    SRDX annual debt to equity ratio is 0.28

    Interest Coverage Ratio

    -
    SRDX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    3
    SRDX piotroski f-score is 3

    Altman Z-Score

    7.85
    SRDX altman z-score is 7.85

    Analyst ratings

    Recent major analysts updates

    Nov 14, 25 Barrington Research
    Underperform
    Aug 11, 25 Barrington Research
    Market Perform
    Apr 30, 25 Needham
    Hold
    Mar 7, 25 Lake Street
    Buy
    Jan 30, 25 Needham
    Hold
    Nov 7, 24 Needham
    Hold
    Aug 5, 24 Needham
    Hold
    May 30, 24 Barrington Research
    Market Perform
    May 29, 24 Sidoti & Co.
    Neutral
    May 29, 24 Needham
    Hold

    Institutional Ownership

    Screeners with SRDX included

    US stocks
    Best performing stocks last month
    Stocks recommended to hold
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    High Altman Z score stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Surmodics, Inc.?
    • Does Surmodics, Inc. pay dividends?
    • What sector is Surmodics, Inc. in?
    • What industry is Surmodics, Inc. in?
    • What country is Surmodics, Inc. based in?
    • When did Surmodics, Inc. go public?
    • Is Surmodics, Inc. in the S&P 500?
    • Is Surmodics, Inc. in the NASDAQ 100?
    • Is Surmodics, Inc. in the Dow Jones?
    • When was Surmodics, Inc.'s last earnings report?
    • When does Surmodics, Inc. report earnings?

    What is the ticker symbol for Surmodics, Inc.?

    The ticker symbol for Surmodics, Inc. is NASDAQ:SRDX

    Does Surmodics, Inc. pay dividends?

    No, Surmodics, Inc. does not pay dividends

    What sector is Surmodics, Inc. in?

    Surmodics, Inc. is in the Healthcare sector

    What industry is Surmodics, Inc. in?

    Surmodics, Inc. is in the Medical Devices industry

    What country is Surmodics, Inc. based in?

    Surmodics, Inc. is headquartered in United States

    When did Surmodics, Inc. go public?

    Surmodics, Inc.'s initial public offering (IPO) was on March 4, 1998

    Is Surmodics, Inc. in the S&P 500?

    No, Surmodics, Inc. is not included in the S&P 500 index

    Is Surmodics, Inc. in the NASDAQ 100?

    No, Surmodics, Inc. is not included in the NASDAQ 100 index

    Is Surmodics, Inc. in the Dow Jones?

    No, Surmodics, Inc. is not included in the Dow Jones index

    When was Surmodics, Inc.'s last earnings report?

    Surmodics, Inc.'s most recent earnings report was on August 8, 2025

    When does Surmodics, Inc. report earnings?

    The next expected earnings date for Surmodics, Inc. is November 25, 2025
    On this page